← FDA Drug Approvals (Drugs@FDA)

ETODOLAC

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ADAPTIS · Approved 2018-11-30

Drug application

FDA Application #

ANDA209888

Application type

Abbreviated New Drug Application (Generic)

Brand name

ETODOLAC

Generic name

ETODOLAC

Active ingredients

ETODOLAC

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ADAPTIS

Manufacturer

Chartwell RX, LLC

First approval

2018-11-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown